Repository of proposed pathways and protein–protein interaction networks in age-related macular degeneration
Abstract Age-related macular degeneration (AMD) is one of the commonest causes of sight loss in the elderly population and to date there is no intervention that slows or prevents early AMD disease progressing to blinding neovascularization or geographic atrophy. AMD is a complex disease and factors...
Guardado en:
Autores principales: | Fran M. Pool, Christina Kiel, Luis Serrano, Philip J. Luthert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8745f6560644aabb7a1696f079360c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Age-related macular degeneration and the aging eye
por: Rita Ehrlich, et al.
Publicado: (2008) -
Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum]
por: Michalska-Małecka K, et al.
Publicado: (2016) -
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Robyn H Guymer, et al.
Publicado: (2008) -
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor
por: Fabrizio Montecucco, et al.
Publicado: (2008) -
Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart
por: Yankun Lyu, et al.
Publicado: (2021)